Aeglea Biotherapeutics competitors

Aeglea Biotherapeutics's competitors include Aptevo Therapeutics, Geron Corporation, Ourotech and Heat Biologics
Add company...
Aeglea Biotherapeutics
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases and cancer.
Aptevo Therapeutics
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
Geron Corporation
Geron is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.
Ourotech
Ourotech is changing the way cancer drugs are tested for the most innovative treatments.
Heat Biologics
Heat Biologics is a clinical-stage company focused on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) fully allogeneic “off-the-shelf” cell based immunotherapy to treat patients with a wide array of cancers and infectious diseases.
Founding Date
Founding Date
2013
Founding Date
2016
Founding Date
1990
Founding Date
2015
Founding Date
2008
Type
Type
Public
Type
Public
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
Austin, US HQ
Locations
Seattle, US HQ
Locations
Menlo Park, US HQ
Canton, US
Locations
Waterloo, CA HQ
Locations
Durham, US HQ
Employees
Employees
4518% increase
Employees
118
Employees
15
Employees
4
Employees
19
Valuation ($)
Valuation ($)
201.5 m
Valuation ($)
119.5 m
Valuation ($)
718 m
Valuation ($)
N/A
Valuation ($)
41.8 m
Facebook likes
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
504
Facebook likes
110

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$14.7m (FY, 2017)
Revenue (est.)
$1.1m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Net income
Net income
($27.2m) (FY, 2017)
Net income
$7m (FY, 2017)
Net income
($27.9m) (FY, 2017)
Net income
N/A
Net income
($12.4m) (FY, 2017)
For sources of this data, please see the company profileDownload Excel

View company profiles

Aptevo Therapeutics
HQ
Seattle, US
Employees
118

Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.

View company
Geron Corporation
HQ
Menlo Park, US
Employees
15

Geron is a clinical stage biopharmaceutical company focused on the development of a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.

View company
Ourotech
HQ
Waterloo, CA
Employees
4

Ourotech is changing the way cancer drugs are tested for the most innovative treatments.

View company
Heat Biologics
HQ
Durham, US
Employees
19

Heat Biologics is a clinical-stage company focused on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) fully allogeneic “off-the-shelf” cell based immunotherapy to treat patients with a wide array of cancers and infectious diseases.

View company